The Hospital for Sick Children
Toronto, Canada
NCT Number: NCT04805268
In the Metabolic Disorder clinic at The Hospital for Sick Children, the investigators identified a male, proband with possible Luft's disease. The investigators hypothesize that Luft's disease is caused by excess or dysregulation of brown/beige fat tissue.
To address the hypothesis, the investigators would like to assess brown fat distribution and activity in this subject.
Looking for future studies?
Notify Me9 year–18 year
All sexes
Interventional
Not applicable
Toronto, Canada
The subject will undergo a fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F FDG PET/CT) at the Diagnostic Imaging unit of The Hospital for Sick Children.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
18F FDG PET/CT imaging (fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography).
Time frame: 1 day
Areas of 18F-FDG uptake on PET colocalizing with regions of fat will be identified on CT (-250to -10 Hounsfield Units) and quantified by Standard Uptake Value (SUV).
The Hospital for Sick Children
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05199246
Carbohydrate Metabolism, Inborn Errors, Congenital Myopathy
Paris, France
View Trial DetailsNCT05200702
Carbohydrate Metabolism, Inborn Errors, Congenital Myopathy
Paris, France
View Trial DetailsNCT05162768
Chronic Disease, Cranial Nerve Diseases
San Diego, California, United States
View Trial DetailsNCT06080568
Metabolic Diseases, Mitochondrial Diseases
Copenhagen, Denmark
View Trial Details